Inventor · disambiguated record
Hongxing Yan
Also filed as: YAN HONGXING
15 granted patents·12 pending applications·74 citations·filing 2004–2024
91Inventor score
Files withGLAXO GROUP LTD10GLAXOSMITHKLINE IP DEV LTD8CALLAHAN JAMES FRANCIS3ASTEX THERAPEUTICS LTD2CALLAHAN JAMES F2
Top patents by PatentIndex Score
27 records- 0190US10485806B2Nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Nov 26, 2019·3 cites·10 claims
- 0289US7276521B2Muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2004·Granted Oct 2, 2007·34 cites·32 claims
- 0388US10272095B2NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 30, 2019·4 cites·18 claims
- 0484US7563803B2M3 muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2007·Granted Jul 21, 2009·5 cites·23 claims
- 0583US7479558B2Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivativesGLAXO GROUP LTD·Filed 2006·Granted Jan 20, 2009·5 cites·69 claims
- 0683US7439255B2Muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2004·Granted Oct 21, 2008·14 cites·31 claims
- 0781US2025084077A1Ether linked triazoles as nrf2 activatorsASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0880US7576096B2Muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2007·Granted Aug 18, 2009·3 cites·5 claims
- 0977US7579361B2Muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2007·Granted Aug 25, 2009·2 cites·19 claims
- 1072US7674789B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Mar 9, 2010·1 cites·71 claims
- 1170US8084449B2Dual pharmacophores—PDE4-muscarinic antagonisticsCALLAHAN JAMES FRANCIS·Filed 2009·Granted Dec 27, 2011·2 cites·13 claims
- 1269US12091409B2Ether linked triazoles as NRF2 activatorsASTEX THERAPEUTICS LTD·Filed 2021·Granted Sep 17, 2024·0 cites·9 claims
- 1369US2023047296A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Application pending·0 cites
- 1467US7906531B2M3 muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2009·Granted Mar 15, 2011·0 cites·19 claims
- 1566US8067408B2Dual pharmacophores—PDE4-muscarinic antagonisticsCALLAHAN JAMES FRANCIS·Filed 2009·Granted Nov 29, 2011·1 cites·3 claims
- 1664US11059816B2Ether linked triazoles as NRF2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jul 13, 2021·0 cites·4 claims
- 1759US2010093765A1Novel compoundsCALLAHAN JAMES F·Filed 2009·Application pending·0 cites
- 1859US2010093766A1Novel compoundsCALLAHAN JAMES F·Filed 2009·Application pending·0 cites
- 1958US2020079759A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 2058US2009048444A1Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one DerivativesGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2150US2019002454A1NRF2 RegulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 2246US8071588B2Dual pharmacophores—PDE4-muscarinic antagonisticsCALLAHAN JAMES FRANCIS·Filed 2009·Granted Dec 6, 2011·0 cites·3 claims
- 2346US2008051416A1Novel CompoundsSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 2445US2006094726A1Quinoline derivatives as nk-2 and nk-3 receptor antagonistsKERNS JEFFREY·Filed 2004·Application pending·0 cites
- 2545US2007185148A1M3 muscarinic acetylchoine receptor antagonistsGLAXO GROUP LTD·Filed 2004·Application pending·0 cites
- 2640US2022002272A1Bisaryl lactams as nrf2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 2737US2018179167A1Nrf2 REGULATORSGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hongxing Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →